MedTrace Logo

Dexmedetomidine After Cesarean for the Treatment of Nausea and Shivering

NCT03370562 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-10-01

No results posted yet for this study

Summary

This is a randomized double blinded trial to determine if a small dose of dexmedetomidine can prevent and relieve nausea and shivering, two of the more common complaints after cesarean delivery.

Conditions

  • Shivering
  • Nausea and Vomiting, Postoperative

Interventions

DRUG

Dexmedetomidine

Administration of 10 mcg intravenous dexmedetomidine

DRUG

Placebo

Administration of normal saline

Sponsors & Collaborators

Principal Investigators

  • Philip E Hess, MD · Beth Israel Deaconess Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-18
Primary Completion
2020-03-20
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03370562 on ClinicalTrials.gov